TABLE 2.
Comparison of the clinical features and serological parameters of the both trails at baseline.
| Characteristics | WWXDD | Colchicine | Difference | |
|---|---|---|---|---|
| Baseline | P | |||
| Age: mean (SD) | 49.85 (15.85) | 51.8 (19.6) | 0.561 | |
| Male, n (%) | 39 (95.12%) | 34 (91.89%) | 0.628 | |
| BMI: mean (SD) | 25.21 (2.44) | 26.99 (3.85) | 0.051 | |
| First instance of gout, n (%) | 7 (17.07%) | 6 (16.22%) | 0.92 | |
| Tophus, n (%) | 12 (29.27%) | 13 (35.14%) | 0.579 | |
| Number of body parts affected, n (%) | 1 | 20 (48.78%) | 22 (59.56%) | 0.779 |
| 2 | 13 (31.71%) | 5 (13.51%) | ||
| 3 | 5 (12.20%) | 5 (13.51%) | ||
| 4 | 2 (4.88%) | 1 (2.70%) | ||
| ≧5 | 1 (2.44%) | 4 (10.81%) | ||
| Body part affected, n (%) | metatarsophalangeal joint (MTPJ) | 12 (29.27%) | 14 (37.84%) | 0.423 |
| foot joints | 28 (68.29%) | 19 (51.35%) | 0.127 | |
| Other lower limb | 13 (31.71%) | 12 (32.43%) | 0.945 | |
| upper limb | 14 (34.15%) | 12 (32.43%) | 0.873 | |
| Joint symptoms score, Q2 (Q1-Q3) | 2 (2–4) | 2 (2–4.5) | 0.266 | |
| CRP mg/L, mean (SD) | 37.11 (32.20) | 27.33 (38.57) | 0.133 | |
| Uric Acid (μmol/L), mean (SD) | 494.63 (151.67) | 490.54 (134.19) | 0.90 | |
| ALT (U/L), mean (SD) | 31.05 (20.11) | 38.29 (40.87) | 0.34 | |
| AST (U/L), mean (SD) | 30.84 (33.29) | 28.37 (27.46) | 0.73 | |
| Cr (μmol/L), mean (SD) | 88.10 (19.12) | 81.41 (22.96) | 0.28 | |
MTPJ: metatarsophalangeal joint; CRP: C-reactive protein; ALT: alanine transaminase; AST: aspartate aminotransferase; Cr: Creatinine; SD: standard deviation.